“[Budget Impact Analysis for Peginterferon Beta-1a in Relapsing Remitting Multiple Sclerosis in Italy]”. 2016. Farmeconomia. Health Economics and Therapeutic Pathways 17 (2S): 37-48. https://doi.org/10.7175/fe.v17i2S.1231.